Qiagen is a top provider of genomic testing technology and a leader in molecular diagnostics and related instruments.


Updates from The Motley Fool

Latest updates on Qiagen from Fool.com.


Stock Performance

QGEN vs. S&P 500 | 2 Year Performance
View Interactive QGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Qiagen.
Current Price: $26.86
Prev Close: $26.52
Open: $26.21
Bid: $26.85
Ask: $26.86
Day's Range: $26.13 - $26.98
52wk Range: $19.94 - $28.04
Volume: 762,802
Avg Vol 930,620
Market Cap: $6.25B
P/E (ttm): 49.11
EPS (ttm): $0.54
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Qiagen.
CAPS Rating 4 out of 5
 
204 Outperform
14 Underperform
CAPS All Stars
 
55 Outperform
1 Underperform

How do you think Qiagen will perform against the market?



You pick for Qiagen is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Peer M. Schatz, CEO

67% Approve

Based on 84 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Qiagen.

Qiagen is a top provider of genomic testing technology and a leader in molecular diagnostics and related instruments.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services